Literature DB >> 12642912

[Clinicopathological analysis of patients with idiopathic pulmonary fibrosis which became acutely exacerbated after video-assisted thoracoscopic surgical lung biopsy].

Tatsuji Enomoto1, Masashi Kawamoto, Shinobu Kunugi, Kumiko Hiramatsu, Keitaro Sakakibara, Jiro Usuki, Arata Azuma, Kyoji Hirai, Kiyoshi Koizumi, Yuh Fukuda, Shoji Kudoh.   

Abstract

Nine patients undergoing video-assisted thoracoscopic surgical (VATS) lung biopsy over a five-year period from 1997 to 2001 with the ultimate diagnosis of usual interstitial pneumonia without underlying connective tissue disease were identified. In two of nine patients, acute exacerbation occurred six days after VATS lung biopsy. We reviewed the clinical records and pathology of all nine cases, and found that the two cases of exacerbation had higher peripheral white blood cell counts and KL-6, lower PaO2, VC and FEV 1, and a longer inhalation of FIO 2 = 1.0 during VATS, and needed a longer period of chest drainage after VATS. Abundant inflammatory cell infiltration and fibroblastic foci were observed in the exacerbation cases. Thus, patients with usual interstitial pneumonia of the idiopathic type, who have high disease activity and low pulmonary function, may be at high risk of acute exacerbation following VATS lung surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12642912

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection.

Authors:  Motoki Yano; Hidefumi Sasaki; Satoru Moriyama; Yu Hikosaka; Keisuke Yokota; Susumu Kobayashi; Masaki Hara; Yoshitaka Fujii
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-24

Review 2.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.